Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

Luigi Rossi, Federica Tomao, Giuseppe Lo Russo, Anselmo Papa, Federica Zoratto, Raffaella Marzano, Enrico Basso, Erika Giordani, Monica Verrico, Fabio Ricci, Giulia Pasciuti, Silverio Tomao, Edoardo Francini
  • Therapeutics and Clinical Risk Management, November 2013, Dove Medical Press
  • DOI: 10.2147/tcrm.s48387
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Federica Tomao, Dr Edoardo Francini, and Dr Anselmo Papa